{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:01:18Z","timestamp":1790499678629,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins & Other Lipid Mediators"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.prostaglandins.2006.10.003","type":"journal-article","created":{"date-parts":[[2006,11,8]],"date-time":"2006-11-08T12:34:18Z","timestamp":1162989258000},"page":"89-98","source":"Crossref","is-referenced-by-count":40,"title":["Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart"],"prefix":"10.1016","volume":"83","author":[{"given":"Yochai","family":"Birnbaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheldon Y.","family":"Freeberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-He","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose R.","family":"Perez-Polo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry F.","family":"Uretsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2006.10.003_bib1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.amjmed.2005.11.013","article-title":"Aspirin to prevent heart attack and stroke: what's the right dose?","volume":"119","author":"Dalen","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.prostaglandins.2006.10.003_bib2","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMra052717","article-title":"Low-dose aspirin for the prevention of atherothrombosis","volume":"353","author":"Patrono","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prostaglandins.2006.10.003_bib3","doi-asserted-by":"crossref","first-page":"9475","DOI":"10.1073\/pnas.92.21.9475","article-title":"Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions","volume":"92","author":"Claria","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.prostaglandins.2006.10.003_bib4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.plefa.2005.05.002","article-title":"Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution","volume":"73","author":"Serhan","year":"2005","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.prostaglandins.2006.10.003_bib5","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1074\/jbc.275.7.4743","article-title":"Stereospecificity of hydrogen abstraction in the conversion of arachidonic acid to 15R-HETE by aspirin-treated cyclooxygenase-2. Implications for the alignment of substrate in the active site","volume":"275","author":"Schneider","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2006.10.003_bib6","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1096\/fj.02-0777fje","article-title":"Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipooxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin","volume":"17","author":"Fiorucci","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.prostaglandins.2006.10.003_bib7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.plefa.2005.05.007","article-title":"The role of aspirin-triggered lipoxins in the mechanism of action of aspirin","volume":"73","author":"Gilroy","year":"2005","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.prostaglandins.2006.10.003_bib8","doi-asserted-by":"crossref","first-page":"10937","DOI":"10.1073\/pnas.1933204100","article-title":"Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa","volume":"100","author":"Fiorucci","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.prostaglandins.2006.10.003_bib9","doi-asserted-by":"crossref","first-page":"5292","DOI":"10.1073\/pnas.96.9.5292","article-title":"Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate","volume":"96","author":"Xu","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.prostaglandins.2006.10.003_bib10","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0022-3565(24)37857-7","article-title":"Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA","volume":"287","author":"Chiang","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.prostaglandins.2006.10.003_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1084\/jem.20040566","article-title":"15-epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation","volume":"200","author":"Paul-Clark","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.prostaglandins.2006.10.003_bib12","doi-asserted-by":"crossref","first-page":"15178","DOI":"10.1073\/pnas.0405445101","article-title":"Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial","volume":"101","author":"Chiang","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.prostaglandins.2006.10.003_bib13","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/CIRCULATIONAHA.106.629907","article-title":"Augmentation of myocardial production of 15-epi-lipoxin A4 by pioglitazone and atorvastatin in the rat","volume":"114","author":"Birnbaum","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.prostaglandins.2006.10.003_bib14","doi-asserted-by":"crossref","first-page":"H1158","DOI":"10.1152\/ajpheart.00096.2006","article-title":"Myocardial protection by pioglitazone, atorvastatin and their combination: mechanisms and possible interactions","volume":"291","author":"Ye","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.prostaglandins.2006.10.003_bib15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cardiores.2004.10.018","article-title":"Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury","volume":"65","author":"Birnbaum","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.prostaglandins.2006.10.003_bib16","doi-asserted-by":"crossref","first-page":"H1960","DOI":"10.1152\/ajpheart.01137.2005","article-title":"Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2","volume":"290","author":"Atar","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.prostaglandins.2006.10.003_bib17","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1126\/science.1119407","article-title":"Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2","volume":"310","author":"Kim","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.prostaglandins.2006.10.003_bib18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.plefa.2005.05.017","article-title":"Liver: the formation and actions of aspirin-triggered lipoxins","volume":"73","author":"Claria","year":"2005","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.prostaglandins.2006.10.003_bib19","doi-asserted-by":"crossref","first-page":"C870","DOI":"10.1152\/ajpcell.1999.277.5.C870","article-title":"Hepatocytes are a rich source of novel aspirin-triggered 15-epi-lipoxin A(4)","volume":"277","author":"Titos","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.prostaglandins.2006.10.003_bib20","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/BF03401642","article-title":"Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation","volume":"2","author":"Claria","year":"1996","journal-title":"Mol Med"},{"key":"10.1016\/j.prostaglandins.2006.10.003_bib21","first-page":"155","article-title":"NADPH-dependent formation of 15- and 12-hydroxyeicosatrienoic acid from arachidonic acid by rat epidermal microsomes","volume":"4","author":"Van Wauwe","year":"1991","journal-title":"Eicosanoids"},{"key":"10.1016\/j.prostaglandins.2006.10.003_bib22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0889-857X(03)00117-0","article-title":"Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entree for resoleomics","volume":"30","author":"Serhan","year":"2004","journal-title":"Rheum Dis Clin North Am"}],"container-title":["Prostaglandins & Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882306001468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882306001468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T22:27:54Z","timestamp":1736634474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882306001468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":22,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S1098882306001468"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2006.10.003","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}